Skip to main content
. 2024 Oct 15;16(10):5357–5370. doi: 10.62347/KJYY7691

Figure 1.

Figure 1

This figure illustrates a comprehensive summary of mutations identified in both the overall and pathogenic categories within the BRCA1/2 genes among gastric cancer (GC) patients utilizing Whole Exome Sequencing (WES). A. Provides an overview of the total count of detected mutations in BRCA1/2 genes among GC patients. B. Specifically highlights the count of pathogenic mutations in BRCA1/2 genes among GC patients.